Nucleus Genomics unveiled Vitruvian, a genetic optimization model it says can select embryo DNA for 14 IQ points, nearly a full standard deviation. The company's own whitepaper shows a smaller real-world gain, and the practice remains ethically contested and largely unregulated.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.